308 related articles for article (PubMed ID: 11336882)
21. Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.
Kelley KM; Rowan BG; Ratnam M
Cancer Res; 2003 Jun; 63(11):2820-8. PubMed ID: 12782587
[TBL] [Abstract][Full Text] [Related]
22. Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression.
Ferguson AT; Lapidus RG; Davidson NE
Oncogene; 1998 Aug; 17(5):577-83. PubMed ID: 9704923
[TBL] [Abstract][Full Text] [Related]
23. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
24. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG
Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol.
Hung H
J Cell Physiol; 2004 Feb; 198(2):197-208. PubMed ID: 14603522
[TBL] [Abstract][Full Text] [Related]
26. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.
Sarvilinna N; Eronen H; Miettinen S; Vienonen A; Ylikomi T
Int J Cancer; 2006 Feb; 118(4):832-40. PubMed ID: 16152593
[TBL] [Abstract][Full Text] [Related]
27. Regulation of hepatic progesterone and estrogen receptors in the female turtle, Chrysemys picta: relationship to vitellogenesis.
Custodia-Lora N; Novillo A; Callard IP
Gen Comp Endocrinol; 2004 Apr; 136(2):232-40. PubMed ID: 15028527
[TBL] [Abstract][Full Text] [Related]
28. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.
Syed V; Ulinski G; Mok SC; Yiu GK; Ho SM
Cancer Res; 2001 Sep; 61(18):6768-76. PubMed ID: 11559549
[TBL] [Abstract][Full Text] [Related]
29. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
30. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
[TBL] [Abstract][Full Text] [Related]
31. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
Hurd C; Dinda S; Khattree N; Moudgil VK
Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683
[TBL] [Abstract][Full Text] [Related]
32. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
[TBL] [Abstract][Full Text] [Related]
33. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.
Dumont JA; Bitonti AJ; Wallace CD; Baumann RJ; Cashman EA; Cross-Doersen DE
Cell Growth Differ; 1996 Mar; 7(3):351-9. PubMed ID: 8838865
[TBL] [Abstract][Full Text] [Related]
34. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
Hall JM; Korach KS
Mol Endocrinol; 2003 May; 17(5):792-803. PubMed ID: 12586845
[TBL] [Abstract][Full Text] [Related]
35. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
[TBL] [Abstract][Full Text] [Related]
36. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.
Smith CL; Nawaz Z; O'Malley BW
Mol Endocrinol; 1997 Jun; 11(6):657-66. PubMed ID: 9171229
[TBL] [Abstract][Full Text] [Related]
37. Expression and hormonal regulation of coactivator and corepressor genes.
Misiti S; Schomburg L; Yen PM; Chin WW
Endocrinology; 1998 May; 139(5):2493-500. PubMed ID: 9564863
[TBL] [Abstract][Full Text] [Related]
38. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
39. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE
Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550
[TBL] [Abstract][Full Text] [Related]
40. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
Huang HJ; Norris JD; McDonnell DP
Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]